诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVO 诺和诺德

美国独立日休市 07-03 13:00:00 EDT

138.87

-4.11

-2.87%

盘后138.60

-0.27-0.19%

16:59 EDT

最高141.52	最低136.01	成交量745.58万
今开141.34	昨收142.98	日振幅3.85%
总市值6,159亿	流通市值4,401亿	总股本44.35亿
成交额10.34亿	换手率0.24%	流通股本31.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":138.87,"timestamp":1720026000000,"preClose":142.98,"halted":0,"volume":7455753,"hourTrading":{"tag":"盘后","latestPrice":138.6,"preClose":138.87,"latestTime":"16:59 EDT","volume":276756,"amount":38423159.5933,"timestamp":1720040380767},"delay":0,"floatShares":3168867506,"shares":4435072811,"eps":2.879408,"marketStatus":"美国独立日休市","marketStatusCode":7,"change":-4.11,"latestTime":"07-03 13:00:00 EDT","open":141.34,"high":141.52,"low":136.01,"amount":1034232829.60824,"amplitude":0.038537,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.879408,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720166400000},"adr":1,"listingDate":363499200000,"adjPreClose":142.98,"adrRate":1,"dividendRate":0.009962,"preHourTrading":{"tag":"盘前","latestPrice":141.32,"preClose":142.98,"latestTime":"09:29 EDT","volume":93083,"amount":13111114.74366,"timestamp":1720013399999},"postHourTrading":{"tag":"盘后","latestPrice":138.6,"preClose":138.87,"latestTime":"16:59 EDT","volume":276756,"amount":38423159.5933,"timestamp":1720040380767},"volumeRatio":3.5026406483301957,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1720756800000,"strike":"140.0","timestamp":1720023481575,"price":3.700000047683716,"volume":1750,"amount":647500,"type":"-"},{"symbol":"NVO","call":false,"expireDate":1720756800000,"strike":"137.0","timestamp":1720023481575,"price":2.299999952316284,"volume":1750,"amount":402500,"type":"+"}]},"impliedVol":0.3545,"impliedVolPercentile":0.7222},"requestUrl":"/m/hq/s/NVO/tweets","defaultTab":"tweets","newsList":[{"id":"2448490746","title":"哈佛研究显示司美格鲁肽与罕见的视觉丧失有关 诺和诺德(NVO.US)领跌减肥药概念股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448490746","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448490746?lang=zh_cn&edition=full","pubTime":"2024-07-04 14:42","pubTimestamp":1720075332,"startTime":"0","endTime":"0","summary":"智通财经获悉，周三发表在医学杂志《美国医学会杂志》上的一项小型研究指出，诺和诺德的畅销减肥药Ozempic和Wegovy可能与一种罕见的视力丧失——非动脉瘤性前部缺血性视神经病变风险增加有关。受该消息拖累，周三，减肥药概念相关股下跌。研究表明，肥胖或超重患者接受GLP-1药物活性成分司美格鲁肽治疗后，发生NAION的可能性是接受非GLP-1药物治疗的患者的7倍多。与此同时，那些使用司美格鲁肽治疗糖尿病的人患NAION的风险增加了四倍多。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","BK4588","IE00BKVL7J92.USD","BK4007","NVO","BK4532","BK4585"],"gpt_icon":0},{"id":"2448457047","title":"24小时环球政经要闻全览 | 7月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2448457047","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448457047?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:41","pubTimestamp":1720053665,"startTime":"0","endTime":"0","summary":"全球热点狙击","market":"sg","thumbnail":"https://img3.gelonghui.com/cc147-5eceb2d2-c772-4b50-9dae-ba8604cf397c.jpg?guru_height=716&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/cc147-5eceb2d2-c772-4b50-9dae-ba8604cf397c.jpg?guru_height=716&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/827901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU2602419157.SGD","LU0238689110.USD","IE00BFSS8Q28.SGD","LU0276348264.USD","IE00BWXC8680.SGD","LU0289960550.SGD","LU0466842654.USD","LU0820562030.AUD","NVDA","TSLA","LU0072462426.USD","LU0175139822.USD","LU0820561818.USD","IE00B7KXQ091.USD","LU0823411888.USD","BK4587","IE00BDCRKT87.USD","LU0061474705.USD","LU0170899867.USD","IE0034235188.USD","IE00BKDWB100.SGD","BK4555","LU0234572021.USD","IE00BMPRXN33.USD","IE0004445239.USD","LU0719512351.SGD","LU2756315318.SGD","LU0109391861.USD","LU1861558580.USD","BK4534","NVO","BK4551","BK4532","BK4581","IE00B19Z9505.USD","BK4579","BK4527","LU2249611893.SGD","LU2063271972.USD","LU1861215975.USD","LU1914381329.SGD","IE00BSNM7G36.USD","LU0082616367.USD","LU0198837287.USD","IE0004445015.USD","LU0320765059.SGD","LU0053666078.USD","BK4585","SG9999015952.SGD","GB00BDT5M118.USD"],"gpt_icon":0},{"id":"2448595450","title":"哈佛研究显示减肥药Ozempic与罕见的视觉丧失有关，诺和诺德一度跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448595450","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448595450?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:34","pubTimestamp":1720053288,"startTime":"0","endTime":"0","summary":"$诺和诺德 $畅销的减肥药Ozempic和Wegovy被指出可能与一种罕见的视力丧失——非动脉瘤性前部缺血性视神经病变风险增加有关。作为Ozempic和Wegovy的主要成分，司美格鲁肽已经经过了超过15年的研究，科学界普遍认为其安全性较高。这项研究涵盖了2017年12月Ozempic获批以来，在马萨诸塞州眼耳医院接受治疗的710名糖尿病患者和979名减肥药物使用者的记录。研究人员比较了首次使用Ozempic或Wegovy的患者与使用其他治疗方法的患者NAION的发病率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070408345295716c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070408345295716c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","BK4585","BK4007","BK4588","BK4532","NVO","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2448154459","title":"隔夜美股全复盘(7.4)| 特斯拉涨逾6%，连涨七日，创一年来最长连涨；英伟达涨逾4%，国会山股神佩洛西购买了120万美元的英伟达股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2448154459","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448154459?lang=zh_cn&edition=full","pubTime":"2024-07-04 07:05","pubTimestamp":1720047914,"startTime":"0","endTime":"0","summary":"特斯拉涨逾6%，连涨七日，创一年来最长连涨；英伟达涨逾4%，国会山股神佩洛西购买了120万美元的英伟达股票","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/827878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0097036916.USD","LU1242518857.USD","LU1435385759.SGD","LU1244550494.USD","LU1670711040.USD","LU","LU2468319806.SGD","LU0264606111.USD","LU2237443549.SGD","09866","LU1282649810.SGD","XPEV","BK4588","META","LU0056508442.USD","IE00BKDWB100.SGD","NIO","LU0320765489.SGD","V","MSFT","ASML","TSLL","03165","PDD","TSM","AMZN","LU0965509101.SGD","LU0690374615.EUR","BABA","EVS.SI","IE00B19Z3B42.SGD","LU0471298777.SGD","IE0002270589.USD","NVDA","DOYU","LU2237443978.SGD","TSLA","LU0130102774.USD","LU0433182093.SGD","03145","AVGO","NVO","AAPL","LU0541501648.USD","LU0385154629.USD","GB00B4QBRK32.GBP","JD","LU2133065610.SGD","GOOG","LU0690374961.EUR","IE00B7SZLL34.SGD","BK4227","LLY"],"gpt_icon":0},{"id":"2448245277","title":"医药行业周报：诺和诺德口服双激动剂在华获批临床 用于减重","url":"https://stock-news.laohu8.com/highlight/detail?id=2448245277","media":"太平洋证券股份...","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448245277?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:00","pubTimestamp":1720022400,"startTime":"0","endTime":"0","summary":"行业要闻：6 月26 日，中国国家药监局药品审评中心官网公示，诺和诺德1 类新药Amycretin 片获批临床，拟用于降低超重或肥胖成人患者的体重。该药为诺和诺德开发的一款口服GLP-1 受体和胰淀素受体的长效共激动剂，为新一代减重疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040819599eff5da9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040819599eff5da9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BZ1G4Q59.USD","BK4007","NVO","BK4532","IE00BKVL7J92.USD","BK4585"],"gpt_icon":0},{"id":"2448482095","title":"减肥药概念股走低 诺和诺德(NVO)跌3.8% 哈佛研究称诺和诺德减肥药或增七倍NAION风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2448482095","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448482095?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:53","pubTimestamp":1720022004,"startTime":"0","endTime":"0","summary":"金吾财讯 | 减肥药概念股走低，诺和诺德(NVO)跌3.8%，礼来(LLY)跌1.85%，辉瑞(PFE)跟跌。据悉，哈佛医学院附属的麻省眼耳医院的研究者发现，诺和诺德公司生产的流行减肥药物Ozempic和Wegovy可能与增加罕见视力丧失的风险相关。研究分析病历后发现，与使用其他减肥药物的人群相比，服用诺和诺德减肥药的患者发生非动脉性前部缺血性视神经病变（NAION）的风险增加了七倍。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277445","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","NVO","SGXZ57979304.SGD","IE00B2B36J28.USD","PFE","LU0061475181.USD","LU0868494617.USD","BK4568","LU0471298777.SGD","LU2237438978.USD","LU0320765059.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0640476718.USD","LU1064131342.USD","LU0289739699.SGD","LU1057294990.SGD","LU1280957306.USD","BK4588","IE00B19Z3B42.SGD","LU0672654240.SGD","IE00B1BXHZ80.USD","LU0456855351.SGD","LU0708995401.HKD","LU1988902786.USD","SG9999013999.USD","LU1814569148.SGD","SG9999002224.SGD","BK4592","LU0234572021.USD","IE00BLSP4452.SGD","SG9999001176.USD","BK4581","LU2468319806.SGD","IE00BBT3K403.USD","LU0417517546.SGD","LU0321505439.SGD","LU0122379950.USD","LU0238689110.USD","LU0689472784.USD","SG9999001176.SGD","LU1267930730.SGD","LU1023059063.AUD","BK4585","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LLY","LU0321505868.SGD"],"gpt_icon":0},{"id":"2448825164","title":"美股异动 | 减肥药概念相关股下跌 诺和诺德(NVO.US)跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448825164","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448825164?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:32","pubTimestamp":1720020761,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，减肥药概念相关股下跌，截至发稿，诺和诺德(NVO.US)跌超4%，礼来(LLY.US)跌1.6%，辉瑞(PFE.US)跌0.34%。哈佛大学附属医院Massachusetts Eye and Ear医生们的分析结果显示，诺和诺德畅销的减肥药Ozempic和Wegovy似乎与患上罕见视觉功能丧失的风险上升有关。针对病历的研究结果显示，相比那些使用其他品牌减肥药的人，使用诺和诺德减肥药来减肥的患者们患上非动脉性前部缺血性视神经病变(NAION)的可能性要高出七倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IE00BZ1G4Q59.USD","BK4007","BK4532","NVO","IE00BKVL7J92.USD","BK4588"],"gpt_icon":0},{"id":"1147733291","title":"哈佛研究结果：减肥药Ozempic与罕见的视觉丧失有关","url":"https://stock-news.laohu8.com/highlight/detail?id=1147733291","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1147733291?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:25","pubTimestamp":1720020311,"startTime":"0","endTime":"0","summary":"7月3日， 哈佛大学医学院附属麻省眼耳医院(Massachusetts Eye and Ear )医生们的分析结果显示，$诺和诺德(NVO)$畅销的减肥药Ozempic和Wegovy似乎与患上罕见视觉功能丧失的风险上升有关。针对病历的研究结果显示，相比那些使用其他减肥药的人，使用诺和诺德减肥药来减肥的患者们患上非动脉性前部缺血性视神经病变（NAION）的可能性要高出六倍以上。受哈佛研究影响，减肥药概念相关股下跌，诺和诺德跌超3%，$礼来(LLY)$跌1.45%，$辉瑞(PFE)$跌0.3%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0868494617.USD","IE00BKVL7J92.USD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LLY","SG9999001176.USD","BK4550","NVO","IE00BLSP4239.USD","LU1551013425.SGD","LU0122379950.USD","BK4581","PFE","IE0002270589.USD","LU1064131342.USD","BK4568","LU2468319806.SGD"],"gpt_icon":0},{"id":"2448063484","title":"美股减肥药概念股下跌，诺和诺德跌3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448063484","media":"港股那点事","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448063484?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:22","pubTimestamp":1720020120,"startTime":"0","endTime":"0","summary":"格隆汇7月3日｜受哈佛研究影响，减肥药概念相关股下跌，诺和诺德(NVO.US)跌3%，礼来(LLY.US)跌1.45%，辉瑞(PFE.US)跌0.3%。哈佛研究结果称，减肥药Ozempic与罕见的视觉丧失有关。               \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-07-03/doc-incawrne8092872.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-07-03/doc-incawrne8092872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","BK4532","IE00BZ1G4Q59.USD","NVO","BK4588","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2448146107","title":"高得不合理！拜登施压：诺和诺德、礼来必须降低减肥药价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2448146107","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448146107?lang=zh_cn&edition=full","pubTime":"2024-07-03 10:32","pubTimestamp":1719973961,"startTime":"0","endTime":"0","summary":"每年带来4110亿美元医疗负担","market":"us","thumbnail":"https://img3.gelonghui.com/557ab-3dceea1b-9e13-4e55-8581-4d9daeaba104.jpg?guru_height=960&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/557ab-3dceea1b-9e13-4e55-8581-4d9daeaba104.jpg?guru_height=960&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/825999","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0320765059.SGD","LU2237438978.USD","LU0122379950.USD","LU0640476718.USD","LU0417517546.SGD","IE0004445239.USD","LU1712237335.SGD","BK4588","LU1064131342.USD","BK4585","IE00B2B36J28.USD","LU0256863811.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2237443549.SGD","LU0820561818.USD","LU2237443622.USD","LU2265009873.SGD","LU1988902786.USD","BK4534","LU0198837287.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","GB00BDT5M118.USD","LU0689472784.USD","LU1023059063.AUD","LU1280957306.USD","LU2264538146.SGD","BK4581","LU0466842654.USD","LU0708995401.HKD","NVO","BK4007","LU0097036916.USD","LU0672654240.SGD","LU1267930730.SGD","LU0456855351.SGD","LU1551013425.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0109391861.USD","LLY","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","LU0882574055.USD","LU1623119135.USD","LU2491049909.HKD","LU0820561909.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2448123811","title":"隔夜美股全复盘(7.3)| 特斯拉涨逾10%，Q2交付量超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2448123811","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448123811?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:02","pubTimestamp":1719968568,"startTime":"0","endTime":"0","summary":"特斯拉涨逾10%，Q2交付量超预期","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/825496","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4592","LU0823414478.USD","LU0080751232.USD","LU0820562030.AUD","RIVN","AMZN","LU1720051017.SGD","LU0672654240.SGD","NVO","IE00BZ1G4Q59.USD","LU2237438978.USD","IE000KEQY171.SGD","MSFT","BK4532","LU2063271972.USD","SG9999015986.USD","LLY","BK4527","LU1814569148.SGD","BABA","LU0238689110.USD","LU0052756011.USD","PDD","LU1839511570.USD","META","LU0198837287.USD","SG9999015952.SGD","LU1551013425.SGD","LU0127658192.USD","AAPL","IE00B775SV38.USD","LU0466842654.USD","LU0310800965.SGD","LU0061475181.USD","PARA","IE00BKDWB100.SGD","LU0820561909.HKD","LU0289739699.SGD","GOOG","IE00B3S45H60.SGD","LU1267930227.SGD","NVDA","IE0003U64NQ7.SGD","LU2264538146.SGD","IE00BLSP4452.SGD","LU0109392836.USD","LU2756315664.SGD","JD","TSLA","LU0149725797.USD","BK4533","IE00B19Z9505.USD","IE00BJT1NW94.SGD","LU2602419157.SGD","TSLL","LU0689472784.USD","LU1064131342.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2448727119","title":"24小时环球政经要闻全览 | 7月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2448727119","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448727119?lang=zh_cn&edition=full","pubTime":"2024-07-03 08:22","pubTimestamp":1719966161,"startTime":"0","endTime":"0","summary":"全球热点狙击","market":"sg","thumbnail":"https://img3.gelonghui.com/d87c8-94f16886-d43e-472c-8b8c-1606f37030ed.jpg?guru_height=813&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d87c8-94f16886-d43e-472c-8b8c-1606f37030ed.jpg?guru_height=813&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/825480","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0672654240.SGD","IE00BJT1NW94.SGD","LU1852331112.SGD","SDS","OEX","IE0003U64NQ7.SGD","AAPL","LU0011850046.USD","LU0308772762.SGD","BK4592","LU2237438978.USD","LU0058720904.USD","NVO","SSO","LU0943347566.SGD","LU0072462426.USD",".SPX","LU0149725797.USD","SH","IE000KEQY171.SGD","OEF","BK4007","LU1023059063.AUD","RIVN","TSLA","LU0256863811.USD","LU0082616367.USD","MSFT","LU1267930730.SGD","LU1861220033.SGD","LLY","LU1064131342.USD","LU1861558580.USD","LU2249611893.SGD","LU0385154629.USD","SPXU","IE00B1XK9C88.USD","LU0097036916.USD","UPRO","LU0471298777.SGD","LU2237443382.USD","LU0882574139.USD","LU2357305700.SGD","LU2237443978.SGD","LU2237443549.SGD","LU0820561909.HKD","IVV","SPY","SG9999015986.USD","ESmain","LU1720051017.SGD"],"gpt_icon":0},{"id":"2448150144","title":"美股异动 | 拜登称其“欺骗美国人民” 礼来(LLY.US)、诺和诺德(NVO.US)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448150144","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448150144?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:03","pubTimestamp":1719929016,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，美国制药公司礼来(LLY.US)及诺和诺德公司(NVO.US)股价走低，截至发稿，这两家公司均下跌超3%。此前，美国总统拜登敦促这两家制药巨头大幅降低其产品价格，包括抗肥胖药物。在外媒发表的一篇文章中，拜登与参议员桑德斯表示，礼来和诺和诺德是大制药公司“欺骗美国人民”的例子。拜登和桑德斯称：“如果不大幅降低这些药物的价格，它们就有可能使美国的医疗保健系统破产。我们不会允许这种情况发生。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0256863811.USD","BK4581","LU0079474960.USD","IE00BZ1G4Q59.USD","LU0672654240.SGD","LU1804176565.USD","LU0097036916.USD","IE00B1BXHZ80.USD","LU2237438978.USD","LU1814569148.SGD","LU2237443622.USD","LLY","BK4534","BK4533","LU0708995401.HKD","LU1057294990.SGD","IE0004445239.USD","LU1280957306.USD","LU2237443549.SGD","LU0882574055.USD","LU1023059063.AUD","LU0058720904.USD","LU0109391861.USD","LU0122379950.USD","LU0417517546.SGD","LU1551013342.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","LU0320765059.SGD","LU1551013425.SGD","LU2237443978.SGD","LU2468319806.SGD","LU0471298777.SGD","LU0238689110.USD","GB00BDT5M118.USD","BK4588","LU0289739699.SGD","LU2491050071.SGD","IE00BJJMRZ35.SGD","LU0061475181.USD","IE0002141913.USD","BK4007","LU2237443382.USD","LU2491049909.HKD","BK4532","LU0385154629.USD","LU2264538146.SGD","NVO","LU1988902786.USD","LU0943347566.SGD"],"gpt_icon":0},{"id":"1101414000","title":"美股异动｜礼来、诺和诺德盘初均跌超3%，拜登敦促降低药品价格","url":"https://stock-news.laohu8.com/highlight/detail?id=1101414000","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1101414000?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:55","pubTimestamp":1719928530,"startTime":"0","endTime":"0","summary":"7月2日，礼来、诺和诺德盘初均跌超3%，消息上，拜登、桑德斯在《今日美国》发表的专栏文章中称，诺和诺德、礼来公司的定价高得不可思议，呼吁降低药品价格。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LLY"],"gpt_icon":0},{"id":"1103992208","title":"开盘 | 美股三大指数低开！特斯拉涨超4%，诺和诺德跌超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103992208","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1103992208?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:30","pubTimestamp":1719927034,"startTime":"0","endTime":"0","summary":"7月2日，美股三大指数集体低开，道指跌0.20%，纳指跌0.40%，标普500指数跌0.30%。特斯拉涨超4%，第二季度交付量443,956辆，高于市场预期。诺和诺德跌超2%，美国总统拜登称诺和诺德必须下调Ozempic（注射用降糖药）和Wegovy（注射用减重药）的价格。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","NVO","BK4581","LU0097036916.USD","LU0466842654.USD","BK4551",".DJI","LU1861215975.USD","LU0689472784.USD","LU1720051017.SGD","LU2063271972.USD","LU1852331112.SGD","LU0823414478.USD","LU2326559502.SGD",".IXIC","LU0820561818.USD","BK4548","LU0316494557.USD","LU0820561909.HKD","IE00BZ1G4Q59.USD","TSLL","LU2087621335.USD","LU2756315664.SGD","TSLA","BK4099","LU1861558580.USD","LU0198837287.USD","BK4511","IE00BWXC8680.SGD","LU1548497426.USD"],"gpt_icon":0},{"id":"2448155627","title":"美股三大期指盘前齐跌，科技股回落，诺和诺德短线走低，欧股跌幅扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2448155627","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448155627?lang=zh_cn&edition=full","pubTime":"2024-07-02 20:22","pubTimestamp":1719922922,"startTime":"0","endTime":"0","summary":"7月2日周二，美股三大期指低开低走，由于市场担忧特朗普胜选后引发通胀和利率走高，美元延续上涨，美债收益率涨势暂歇。今日公布的数据显示，欧元区6月通胀如期放缓，但未能提振欧股。美股三大期指齐跌 科技股集体走低道指期货跌0.34%，标普500指数期货跌0.45%，纳斯达克100指数期货跌0.56%。个股方面，诺和诺德短线走低，一度跌超3%。欧股跌幅扩大，法股回调欧股低开低走，各国股指全数下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021805359565bf8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021805359565bf8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IE00BZ1G4Q59.USD","BK4007","BK4532","NVO","TTTN","IE00BKVL7J92.USD","BK4588"],"gpt_icon":0},{"id":"1148769207","title":"拜登：诺和诺德减肥药必须降价 ","url":"https://stock-news.laohu8.com/highlight/detail?id=1148769207","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1148769207?lang=zh_cn&edition=full","pubTime":"2024-07-02 20:19","pubTimestamp":1719922788,"startTime":"0","endTime":"0","summary":"当地时间周二，美国总统拜登和参议员伯尼·桑德斯在《美国今日》发表的一篇评论文章中表示，诺和诺德必须大幅降低Ozempic和Wegovy的价格。如果诺和诺德和其他制药公司拒绝在我国大幅降低处方药价格并结束他们的贪婪行为，我们将尽我们所能来“帮助”他们终结这种行为。诺和诺德盘前短线走低，一度跌超3%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":0},{"id":"2448158149","title":"诺和诺德美股盘前短线走低，一度跌超3%，美国总统拜登表示，诺和诺德必须降低Ozempic和Wegovy的价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2448158149","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448158149?lang=zh_cn&edition=full","pubTime":"2024-07-02 20:02","pubTimestamp":1719921725,"startTime":"0","endTime":"0","summary":"更多消息，持续更新中","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3718630","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3718630","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["NVO","BK4007","BK4588","IE00BZ1G4Q59.USD","BK4585","BK4532","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2448122954","title":"美国药价暴涨40%! 超三成人“望药兴叹”，拜登急推措施应对","url":"https://stock-news.laohu8.com/highlight/detail?id=2448122954","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448122954?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:00","pubTimestamp":1719817204,"startTime":"0","endTime":"0","summary":"据悉，美国的医疗保险D部分，正式称为Medicare Part D，是Medicare计划中专门针对处方药费用的保险部分。GoodRx的数据显示，32%的美国人认为负担不起是药房无法配药的主要原因，而20%的人将其归咎于药品短缺。美国总统拜登对药品价格问题给予了高度重视，尤其是在大选临近之际。然而事实核查显示，拜登实际上将医疗保险下的胰岛素费用上限设定为每月35美元。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143473.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY","NVO","GDRX"],"gpt_icon":1},{"id":"2446768274","title":"诺泰生物抓住减肥药风口","url":"https://stock-news.laohu8.com/highlight/detail?id=2446768274","media":"经济观察报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446768274?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:39","pubTimestamp":1719589172,"startTime":"0","endTime":"0","summary":"经济观察网 记者 张铃 6月20日，诺泰生物（688076.SH）披露生物医药行业首份半年度业绩预告，预计2024年上半年归母净利润可达1.8亿元—2.5亿元，同比增加330%—497%。这份成绩单超出市场预期，诺泰生物当天盘中触及涨停。此后一周，诺泰生物连续6个交易日上涨，股价累计上涨近30%，创下自2021年7月以来新高。诺泰生物是多肽...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O2txroct-TQUskQHYpzm-Q0-w8TtxMDSQwrAHpXhf2HPoAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O2txroct-TQUskQHYpzm-Q0-w8TtxMDSQwrAHpXhf2HPoAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240628A0B2OO00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240628A0B2OO00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["NVO","BK4532","BK4585","BK4588","IE00BZ1G4Q59.USD","BK4007","IE00BKVL7J92.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.0334},{"period":"1month","weight":0.024},{"period":"3month","weight":0.1203},{"period":"6month","weight":0.3103},{"period":"1year","weight":0.7421},{"period":"ytd","weight":0.3424}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0448},{"period":"3month","weight":0.0748},{"period":"6month","weight":0.1785},{"period":"1year","weight":0.2426},{"period":"ytd","weight":0.1602}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S于1989年成立，由两家丹麦公司，诺德根措夫特A/S和Novo工业A/S的合并而成。诺和诺德是一家全球性医疗保健公司，糖尿病治疗的全球领先者。公司拥有业界最广泛的糖尿病产品组合，其中包括新一代胰岛素，现代的完整产品组合，以及作为一个人每日一次的GLP-1类似物之一。此外，诺和诺德在血友病关怀，生长激素疗法和激素替代疗法中也处于领先地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.534884,"avgChangeRate":0.122207},{"month":2,"riseRate":0.604651,"avgChangeRate":0.027007},{"month":3,"riseRate":0.465116,"avgChangeRate":0.01259},{"month":4,"riseRate":0.627907,"avgChangeRate":0.016402},{"month":5,"riseRate":0.545455,"avgChangeRate":0.017073},{"month":6,"riseRate":0.704545,"avgChangeRate":0.027554},{"month":7,"riseRate":0.5,"avgChangeRate":0.006491},{"month":8,"riseRate":0.511628,"avgChangeRate":0.000647},{"month":9,"riseRate":0.581395,"avgChangeRate":0.000639},{"month":10,"riseRate":0.511628,"avgChangeRate":-0.000902},{"month":11,"riseRate":0.627907,"avgChangeRate":0.028932},{"month":12,"riseRate":0.744186,"avgChangeRate":0.054828}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}